ADC Therapeutics is a commercial-stage oncology-focused biotechnology company developing ADCs for patients with hematological malignancies & solid tumors.

Atopic Dermatitis Control Tool (ADCT) is a validated, brief and easily scored tool for use in clinical practice and clinical research. Its six concise questions allow patients and physicians to …

Find the latest ADC Therapeutics SA (ADCT) stock quote, history, news and other vital information to help you with your stock trading and investing.

Mar 25, 2025 · ADCT-602. The only other project that ADCT highlights in their pipeline is the anti-CD22 antibody-drug conjugate ADCT-602. This is being targeted for patients with B-cell ALL, …

2 days ago · Get a real-time ADC Therapeutics SA (ADCT) stock price with an overview of financials, statistics, forecasts, charts and more.

The evaluation of global atopic dermatitis control is key to minimizing disease burden. The Atopic Dermatitis Control Tool (ADCT) has been developed for this purpose. Participants (diagnosed …

Nov 6, 2019 · The Atopic Dermatitis Control Tool (ADCT©) is a brief patient self-administered instrument designed and validated to assess atopic dermatitis (AD) control; six AD symptoms …

Nov 6, 2019 · Background: The Atopic Dermatitis Control Tool (ADCT©) is a brief patient self-administered instrument designed and validated to assess atopic dermatitis (AD) control; six …

Nov 21, 2024 · Introduction: The Atopic Dermatitis Control Tool (ADCT) assesses six concepts regarding patient-perceived control of atopic dermatitis (AD) in adults and adolescents with …

Nov 21, 2024 · The Atopic Dermatitis Control Tool (ADCT) assesses six concepts regarding patient-perceived control of atopic dermatitis (AD) in adults and adolescents with AD. This …